Clinical Significance of Peripheral Blood Lymphocyte Subtypes and Cytokines in Patients with Hepatocellular Carcinoma Treated with TACE
Open Access
- 1 February 2022
- journal article
- research article
- Published by Taylor & Francis in Cancer Management and Research
- Vol. ume 14, 451-464
Abstract
Purpose: To examine the clinical significance of circulating lymphocyte subtypes and cytokines in patients with hepatocellular carcinoma (HCC) undergoing transarterial chemoembolization (TACE). Patients and Methods: We enrolled 53 patients and assessed lymphocyte subsets (CD4+ T cells, CD8+ T cells, CD4+/CD8+ cell ratio, natural killer cells, and regulatory T cells) and cytokines (interleukin [IL]-2, IL-4, IL-6, IL-10, and interferon [IFN]-γ) on the day before TACE, and 1 day and 4– 8 weeks thereafter. The correlation between baseline inflammatory markers and IL-6, the differences between clinical subgroups, and the prognostic baseline inflammatory values and changes therein were analyzed. Results: We found that baseline IL-6 was positively correlated with IL-10 and IFN-γ. Univariate analysis revealed that patients with higher baseline IL-6, IL-10, and IFN-γ levels had worse liver function and greater tumor burden, suggesting a poor prognosis. Multivariate analysis showed that higher baseline IFN-γ levels were associated with a shorter time to tumor progression (hazard ratio [HR] = 1.912; 95% confidence interval [CI] = 1.013– 3.607; p = 0.045), and higher IL-10 levels were associated with poor overall survival (HR = 2.576; 95% CI = 1.237– 5.364; p = 0.011). Baseline lymphocyte subtypes and changes therein did not have any significant association with prognosis. Conclusion: This study confirmed the association between inflammation and poor prognosis. The prognostic significance of IFN-γ was different from previous studies, while the prognostic significance of lymphocyte subtypes remains to be verified.Keywords
This publication has 46 references indexed in Scilit:
- Effect of Transcatheter Arterial Chemoembolization Combined with Argon–Helium Cryosurgery System on the Changes of NK Cells and T Cell Subsets in Peripheral Blood of Hepatocellular Carcinoma PatientsCell Biochemistry and Biophysics, 2015
- Change in inflammatory cytokine profiles after transarterial chemotherapy in patients with hepatocellular carcinomaCytokine, 2013
- Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cellsNature Medicine, 2013
- Serum interferon gamma level predicts recurrence in hepatocellular carcinoma patients after curative treatmentsInternational Journal of Cancer, 2013
- Increased Circulating Th17 Cells after Transarterial Chemoembolization Correlate with Improved Survival in Stage III Hepatocellular Carcinoma: A Prospective StudyPLOS ONE, 2013
- Pituitary homeobox 2 (PITX2) protects renal cancer cell lines against doxorubicin toxicity by transcriptional activation of the multidrug transporter ABCB1International Journal of Cancer, 2013
- Dual biological effects of the cytokines interleukin-10 and interferon-γCancer Immunology, Immunotherapy, 2011
- Enhancement of tumor‐specific T‐cell responses by transcatheter arterial embolization with dendritic cell infusion for hepatocellular carcinomaInternational Journal of Cancer, 2009
- Unmasking of α-Fetoprotein-Specific CD4+ T Cell Responses in Hepatocellular Carcinoma Patients Undergoing EmbolizationThe Journal of Immunology, 2007
- Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironmentCancer Cell, 2006